Qiagen buys SABiosciences for $90mm in cash

Nov 2009

Qiagen NV will buy closely held PCR assay panel manufacturer SABiosciences for $90mm in cash.

Biotechnology
- Drug Discovery Tools
  - Bioinformatics
- Pharmacogenetics-Pharmacogenomics
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
Pharmaceuticals
Research, Analytical Equipment & Supplies
- PCR & Amplification Tools

Acquisition
- Intra-Biotech Deal
- Full Acquisition
- Payment Includes Cash
- Acquisition of Private Biotech

Already a Strategic Transactions subscriber? You have access to the full deal record through your subscription

Want to become a subscriber? Subscribers get more deal details, updates, deal financials and deal products.

Questions?

Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com

Related Companies

Qiagen buys SABiosciences for $90mm in cash

All set! This article has been sent to my@email.address.

All fields are required. For multiple recipients, separate email addresses with a semicolon.

DCD.EmailPopout.Notice